We are live on ! Find out more
HAE icon

Haemonetics

309 hedge funds and large institutions have $4.42B invested in Haemonetics in 2024 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 124 increasing their positions, 89 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 89

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

17% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 42

3.48% more ownership

Funds ownership: 109.15%112.62% (+3.5%)

2% more call options, than puts

Call options by funds: $42.5M | Put options by funds: $41.7M

1% more funds holding

Funds holding: 306309 (+3)

2% less capital invested

Capital invested by funds: $4.49B → $4.42B (-$70.9M)

Holders
309
Holders Change
+3
Holders Change %
+0.98%
% of All Funds
4.07%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
49
Increased
124
Reduced
89
Closed
42
Calls
$42.5M
Puts
$41.7M
Net Calls
+$767K
Net Calls Change
-$1.31M
Name Holding Trade Value Shares
Change
Change in
Stake
CM
176
Crestline Management
Texas
$453K +$60K +747 +15%
SOADOR
177
State of Alaska Department of Revenue
Alaska
$447K -$12K -150 -3%
Public Employees Retirement Association of Colorado
178
Public Employees Retirement Association of Colorado
Colorado
$434K
KTA
179
Keeley-Teton Advisors
Illinois
$429K -$69.9K -870 -14%
BA
180
Bridgewater Associates
Connecticut
$421K -$196K -2,434 -31%
Janney Montgomery Scott
181
Janney Montgomery Scott
Pennsylvania
$402K +$413K +5,147 New
II
182
Inspire Investing
Idaho
$401K +$562 +7 +0.1%
BC
183
Bridgefront Capital
Texas
$395K +$407K +5,065 New
GAM
184
Gotham Asset Management
New York
$384K
CAPTRUST Financial Advisors
185
CAPTRUST Financial Advisors
North Carolina
$380K +$50.1K +624 +15%
DFCM
186
Dark Forest Capital Management
Puerto Rico
$369K +$379K +4,720 New
CWM
187
CIBC World Markets
New York
$367K +$377K +4,696 New
NSIM
188
North Star Investment Management
Illinois
$365K
Corient Private Wealth
189
Corient Private Wealth
Florida
$364K +$2.97K +37 +0.8%
TRCT
190
Tower Research Capital (TRC)
New York
$347K +$112K +1,399 +46%
QT
191
Quantbot Technologies
New York
$345K +$355K +4,415 New
Verition Fund Management
192
Verition Fund Management
Connecticut
$342K +$113K +1,411 +48%
SSA
193
Schonfeld Strategic Advisors
New York
$333K -$54K -672 -14%
First Trust Advisors
194
First Trust Advisors
Illinois
$328K -$1.66M -20,663 -83%
EF
195
Empowered Funds
Pennsylvania
$319K +$328K +4,086 New
YMRC
196
Yorktown Management & Research Company
Virginia
$312K
TAM
197
Tocqueville Asset Management
New York
$306K
VPIM
198
Vanguard Personalized Indexing Management
California
$297K +$305K +3,803 New
SAM
199
Securian Asset Management
Minnesota
$296K -$8.03K -100 -3%
VCA
200
Verdence Capital Advisors
Maryland
$295K +$884 +11 +0.3%

HAE Hedge Fund Activity: Q4 2024 in Review

309 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q4 2024, worth a combined $4.42B — down 1.6% from $4.49B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new HAE positions and 42 closed out — a net gain of 7 holders — while 124 added to existing stakes and 89 trimmed.

The largest buyer was Neuberger Berman Group, adding an estimated $31.5M. The largest seller was Brown Advisory, cutting an estimated $34.4M.

  • 309 institutional investors held Haemonetics (HAE) as of Q4 2024, up from 306 in Q3 2024.
  • Funds reported $4.42B of Haemonetics stock for Q4 2024, down 1.6% quarter-over-quarter.
  • 49 funds opened new Haemonetics positions in Q4 2024 and 42 closed out, a net change of +7 holders.
  • The largest Haemonetics buyer in Q4 2024 was Neuberger Berman Group, an estimated $31.5M added.
  • The largest Haemonetics seller in Q4 2024 was Brown Advisory, an estimated $34.4M sold.

Based on aggregated 13F filings for Q4 2024.